InPharmX Inc., DBA University Learning Systems Phone: 1-800-940-5860 Email: info@universitylearning.com
Professional learning online at a desk
← All on demand pharmacology CE/CME

On demand pharmacology CE/CME

Pharmacology of GI Conditions

FormatSelf-paced onlineRecordedFebruary 27, 2024AccessAvailable now
Log in to register

About this course

Learn at your own pace.

Comprehensive CME program on gastrointestinal (GI) disorders designed for primary care providers. Topics include IBS and IBD management, elevated liver enzymes, celiac disease, GERD, Barrett’s esophagus, probiotics and C. difficile, abdominal pain, peptic ulcer disease, colon cancer prevention, chronic diarrhea, constipation, diverticular disease, and GI bleeding. Learn evidence-based diagnostic tools, treatment options, and clinical updates for effective GI care.

Educational information

Designed for meaningful, practical learning.

Sessions

Session
2024-02-27 Assessing Abdominal Pain and Inflammatory Bowel Disease Update

Tuesday, February 27, 2024

Speaker: Dr. Peter S. Buch Credit hours: 2.5 ACPE UAN: 0741-0000-24-008-H01-P

Learning objectives
  1. Define the appropriate workup for several interactive cases of acute abdominal pain.
  2. Illustrate the pitfalls in making a diagnosis. Inflammatory Bowel Disease Update:
  3. Distinguish Inflammatory Bowel Disease (IBD) from Irritable Bowel Syndrome (IBS).
  4. Describe the workup of IBD. 3. Distinguish Crohn’s Disease from Ulcerative Colitis.
  5. Choose the “best” treatments for Crohn’s Disease and Ulcerative Colitis. 6. Discuss controversies surrounding IBD.
2024-02-27 Irritable Bowel Syndrome, Elevated Liver Function Tests, Dysphagia, Dyspepsia, GERD, Barrett’s and the Primary Care Provider and Probiotics, Prebiotics, C. diff.

Wednesday, March 27, 2024

Speaker: Dr. Peter S. Buch Credit hours: 5 ACPE UAN: 0741-0000-24-007-H01-P

Learning objectives
  1. IRRITABLE BOWEL SYNDROME: TOOLS FOR SUCCESSFUL TREATMENT:
  2. Recognize the various manifestations of IBS.
  3. Distinguish IBS from Inflammatory Bowel Disease (IBD).
  4. Examine the usefulness of “Alarm Symptoms” .
  5. Choose the best treatments for IBS .
  6. BOOTCAMP FOR ELEVATED LIVER FUNCTION TESTS:
  7. Define Non Alcoholic Fatty Liver Disease (NAFLD) and Non Alcoholic Steato Hepatitis (NASH).
  8. Identify at risk patients and review treatment options.
  9. Recognize frequently encountered gallbladder and common duct clinical dilemmas.
  10. Describe what a primary care provider should know about Hepatitis
  11. CELIAC DISEASE OR SOMETHING ELSE? :
  12. Describe the varied clinical manifestations of Celiac Disease (Sprue).
  13. Define the workup of Celiac Disease especially when a patient is already on a self imposed gluten free diet.
  14. Recognize the entity of Non Celiac Gluten Sensitivity.
  15. Identify how the symptoms of Celiac Disease, Non Celiac Gluten sensitivity, and Irritable Bowel Syndrome can be identical.
  16. DYSPHAGIA, DYSPEPSIA, GERD, BARRETT’S AND THE PRIMARY CARE PROVIDER:
  17. Distinguish gastro esophageal reflux disease (GERD) from dyspepsia.
  18. Acknowledge the true risks of chronic proton pump inhibitor use. 15. Update your knowledge on esophageal diseases.
  19. Delineate the risk of Barrett’s Esophagus and esophageal cancer.
2024-03-01 Clinical Dilemmas in GI Bleeding: and Diverticular Dilemmas

Friday, March 1, 2024

Speaker: Dr. Peter S. Buch Credit hours: 2.5 ACPE UAN: 0741-0000-24-010-H01-P

Learning objectives
  1. CLINICAL DILEMMAS IN GI BLEEDING:
  2. Describe the limitations of colonoscopy.
  3. Recognize the importance of “Alarm Symptoms”.
  4. Describe advanced endoscopic techniques that are used to evaluate GI bleeding.
  5. Recognize the safe use of anti platelet and anticoagulation meds post GI bleeding.
  6. DIVERTICULAR DILEMMAS:
  7. Cite risk factors in developing diverticular diseases.
  8. Explore controversy surrounding antibiotic use in uncomplicated diverticulitis
  9. Elaborate on various treatment modalities for bleeding diverticulitis.
  10. Identify new surgical paradigms.
  11. IRRITABLE BOWEL SYNDROME: TOOLS FOR SUCCESSFUL TREATMENT
  12. C. Celiac Disease or Something Else?
  13. Dysphagia, Dyspepsia, GERD, Barrett’s and the Primary Care Provider
  14. Assessing Abdominal Pain: A Practical Review
  15. Peptic Ulcer Disease and Helicobacter Highlights
  16. Colon Cancer Evaluation and Prevention
  17. Evaluation and Treatment of Chronic Diarrhea
  18. CONSTIPATION CONUNDRUMS:
  19. Clinical Dilemmas in GI Bleeding
  20. Diverticular Dilemmas
2024-03-01 Peptic Ulcer Disease and Helicobacter Highlights, Colon Cancer Evaluation and Prevention, Evaluation and Treatment of Chronic Diarrhea, and Constipation Conundrums:

Friday, March 1, 2024

Speaker: Dr. Peter S. Buch Credit hours: 5 ACPE UAN: 0741-0000-24-009-H01-P

Learning objectives
  1. PEPTIC ULCER DISEASE AND HELICOBACTER HIGHLIGHTS:
  2. Identify the importance of risk factors in the development of UGI bleeding.
  3. Select appropriate candidates for long term PPI therapy.
  4. Review non invasive ways of making a H pylori diagnosis.
  5. Manage antibiotic therapy for Helicobacter 2024.
  6. COLON CANCER EVALUATION AND PREVENTION: WHAT’S NEW?:
  7. Show the best practices that lead to colon cancer prevention.
  8. Review types of polyps and their consequences.
  9. Review the pitfalls of colonoscopy screening.
  10. Show reasonable alternatives to colonoscopy.
  11. EVALUATION AND TREATMENT OF CHRONIC DIARRHEA:
  12. Recognize the common sources of chronic diarrhea including: Irritable Bowel Syndrome, Inflammatory Bowel Disease, Pancreatic Insufficiency, Post cholecystectomy diarrhea, Sprue, Microscopic Colitis.
  13. Review treatment options.
  14. CONSTIPATION CONUNDRUMS:
  15. Recognize specialized, advanced testing for constipated patients unresponsive to standard care.
  16. Recognize fecal overflow incontinence.
  17. Recognize how Peripheral Acting Mu Opioid Receptor Antagonists are useful in treating opioid induced constipation.

Faculty

Portrait of Dr. Peter S. Buch, ULS faculty member

Dr. Peter S. Buch, MD, AGAF, FACP

Clinical Gastroenterologist and Educator · GI Educator

A clinical gastroenterologist with more than 30 years of teaching experience. His case-based, interactive style connects evidence with everyday clinical decisions.

Professional profile ↗

Accreditation

Target audience

Pharmacists, Nurse Practitioners, Physicians, Physician Assistants, Nurses

PHARMACISTS

  • University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. 
  • These programs are accredited for all pharmacists.
  • This course provides 15 hours or 1.5 CEUs.
  • Credit for this course expires on February 27, 2027.

NURSES

  • This course provides 15 hours (1.5 CEU)
  • University Learning Systems is approved by the California Board of Registered Nursing, Provider Number CEP 11409, and CE Broker Tracking #50-11357:
  • University Learning Systems is approved by CE Broker for Florida, Georgia, Arkansas, District of Columbia, Georgia, New Mexico, and West Virginia, Boards of Nursing. 
  • The same hours submitted to renew NP certification may be submitted to a State Board of Nursing for re-licensure.

OTHER PROFESSIONS

  • CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.

  • CANADIAN PHARMACISTS:Canadian Council on Continuing Education in Pharmacy (CCCEP)accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE). 

  • CANADIAN PHYSICIANS: Members of the College of Family Physicians of Canada are eligible to receive up to 15 MAINPRO-M1 credits for participation in this activity due to reciprocal agreement with the American Academy of Family Physicians

  • Other healthcare professionals should confirm acceptance and reporting requirements with their licensing or certification board

Requirements and reporting

  • University Learning Systems reports pharmacy credit through CPE Monitor using the participant’s eNABPID number and date of birth.
  • University Learning Systems is approved by CE Broker, for pharmacy, medicine and nursing for participating states,  Tracking #50-11357. Participant's state license number is required for reporting.
  • Credit is based on completed evaluations for registered sessions. 
  • Credit is awarded per session; partial session credit is not available, and breaks are excluded.
  • Other eligible participants receive an applicable statement of credit after completing the required documentation.

Review complete ULS accreditation statements →

Course fees

DescriptionPrice
Default 15 Hours$250

Begin today

Ready when you are.

Log in to register